THC Therapeutics, Inc.

OTCPK:THCT Stock Report

Market Cap: US$38.9k

THC Therapeutics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Scott Cox

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenure5yrs
Board average tenure7yrs

Recent management updates

Recent updates

CEO

Scott Cox (52 yo)

1.3yrs

Tenure

Mr. Scott A. Cox serves as Chief Executive Officer, Chief Financial Officer & Director at THC Therapeutics, Inc. He has been Senior Vice President of Corporate Development at NewBridge Global Ventures, Inc...

Leadership Team

NamePositionTenureCompensationOwnership
Brandon Romanek
Chief Information Officer8yrsUS$187.75k27.1%
$ 10.5k
Scott Cox
CEO, CFO & Director1.3yrsno datano data
Victor Nacif
Head of Design5yrsno datano data

5.0yrs

Average Tenure

Experienced Management: THCT's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Brandon Romanek
Chief Information Officer8yrsUS$187.75k27.1%
$ 10.5k
Scott Cox
CEO, CFO & Director1.3yrsno datano data
Cory Klippsten
Member of Advisory Board6.9yrsno datano data
Michael Terpin
Chairman of the Advisory Board7yrsno datano data
Clifford Sarkin
Member of Board of Advisors7yrsno datano data

7.0yrs

Average Tenure

52yo

Average Age

Experienced Board: THCT's board of directors are considered experienced (7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 15:51
End of Day Share Price 2025/01/13 00:00
Earnings2024/04/30
Annual Earnings2023/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

THC Therapeutics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution